Study of Emu Oil vs. Placebo for Vulvar Pain in Women.
- Conditions
- VulvodyniaVestibulodynia
- Interventions
- Other: Emu OilOther: Inert oil
- Registration Number
- NCT01295268
- Lead Sponsor
- William Beaumont Hospitals
- Brief Summary
The goal of this study is to determine if vulvar (external female genitalia) pain is decreased with emu oil over a similar placebo oil (no active ingredient) by using measurement devices, examinations, and questionnaires. Topical emu oil has not been scientifically studied for this condition yet, but related reports show no significant side effects or potential benefits.
A total of 30 women will participate in the study at William Beaumont Hospital, Royal Oak.
- Detailed Description
* Women of all ages with vulvar pain may participate in this trial.
* Women will be randomized into 2 groups--a treatment group or placebo group for the 1 month study.
* At the end of the study, those in the placebo group may choose to participate in a 1 month follow-up evaluation using emu oil.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 1
- Women with vulvar pain upon q-tip exam of > 3/10 at 2 or more sites tested.
- Age 18 or older.
- Capable of giving informed consent.
- Capable and willing to follow all study procedures.
- Pregnant women or those intending to become pregnant during the study period.
- Vaginitis (may be treated, then tested later).
- Vulvar disease (other than vulvodynia)-lichen planus, lichen sclerosis, neoplasia, tissue damage due to radiation.
- The subject is deemed unsuitable for enrollment by the investigators based on their history or physical examination.
- Neuropathy.
- Currently in pelvic floor physical therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Emu Oil Emu Oil - inert oil Inert oil -
- Primary Outcome Measures
Name Time Method The change in the Global Response Assessment (GRA) for vulvar pain. After 1 month of intervention Those "moderately" or "markedly" improved on the GRA are responders
- Secondary Outcome Measures
Name Time Method The change in vulvar pain levels After 1 month of intervention Based on a pain visual analog scale (VAS) and vulvalgesiometer evaluations.
Trial Locations
- Locations (1)
Beaumont Women's Urology Center
🇺🇸Royal Oak, Michigan, United States